Breaking news
Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics
By analyzing blood serum proteomics alongside gastric tumors' omics profiles, researchers found immune features coinciding with treatment response and survival.
International Commission to Expand Molecular Testing Access for Cancer Patients
The Lancet Oncology Commission, led by the University of Glasgow, will identify the obstacles to access and generate solutions to reduce global inequities in precision care.
Drug Response Variants May Be Distinct in Somatic, Germline Samples
Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.
Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis
Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.
Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff
A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcare
G42 will be the sole laboratory partner for SomaLogic's SomaScanPlatform for the life sciences and healthcare markets in the UAE and Saudi Arabia.
Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab
Under the agreement, the Arima Gene Fusion Test will become available in the first half of this year through Protean BioDiagnostics' laboratory in Orlando, Florida.
De-Extinction Firm Colossal Biosciences Raises $150M in Series B Round
The company also announced plans to restore and reintroduce the extinct dodo bird through a newly formed avian genomics division.
Quantum-Si Laying off 12 Percent of Workforce
The restructuring, which is intended to decrease costs and streamline the firm, comes as it begins commercialization of its Platinum protein sequencing platform.